- $26.88bn
- $39.55bn
- $4.50bn
- 59
- 32
- 84
- 59
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 3,873 | 3,795 | 3,828 | 4,129 | 4,498 |
Cost of Revenue | |||||
Gross Profit | 2,062 | 1,856 | 1,740 | 1,846 | 1,937 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 3,079 | 3,220 | 3,522 | 3,678 | 4,112 |
Operating Profit | 793 | 575 | 306 | 451 | 386 |
Gain / Loss on Sale of Assets | |||||
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 383 | 345 | 61.4 | -57.9 | -39.8 |
Provision for Income Taxes | |||||
Net Income After Taxes | 439 | 441 | 56.6 | -40.9 | -30.3 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Extraordinary Items | |||||
Net Income | 433 | 439 | 49 | -47.4 | -41 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 433 | 439 | 49 | -47.4 | -41 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 1.46 | 1.05 | 0.407 | 0.147 | 0.136 |
Dividends per Share |